Intuitive Surgical, Inc. Increase (Decrease) in Deferred Income Taxes
Intuitive Surgical, Inc. (ISRG) reported Increase (Decrease) in Deferred Income Taxes of -$370.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-21.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2026-07-21
- Intuitive Surgical, Inc. increase (decrease) in deferred income taxes for the quarter ending 2026-06-30 was -$31.00M, a 205.08% decline year-over-year.
- Intuitive Surgical, Inc. increase (decrease) in deferred income taxes for the quarter ending 2026-03-31 was -$339.30M.
- Intuitive Surgical, Inc. increase (decrease) in deferred income taxes for the quarter ending 2025-12-31 was $39.50M, a 28.25% increase year-over-year.
- Intuitive Surgical, Inc. increase (decrease) in deferred income taxes for the quarter ending 2025-09-30 was -$88.00M, a 236.01% decline year-over-year.
- Intuitive Surgical, Inc. increase (decrease) in deferred income taxes for fiscal 2025 was -$19.10M, a 114.12% decline from fiscal 2024.
- Intuitive Surgical, Inc. increase (decrease) in deferred income taxes for fiscal 2024 was $135.30M, a 51.82% decline from fiscal 2023.
- Intuitive Surgical, Inc. increase (decrease) in deferred income taxes for fiscal 2023 was $280.80M, a 51.54% increase from fiscal 2022.
- Intuitive Surgical, Inc. increase (decrease) in deferred income taxes for fiscal 2022 was $185.30M, a 196.01% increase from fiscal 2021.
| Period end | Increase (Decrease) in Deferred Income Taxes 3 month | Increase (Decrease) in Deferred Income Taxes 6 month | Increase (Decrease) in Deferred Income Taxes 9 month | Increase (Decrease) in Deferred Income Taxes 12 month | Increase (Decrease) in Deferred Income Taxes 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$31.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-21 | -$370.30M 10-Q · filed 2026-07-21 | -$330.80M derived: sum of 3 quarters · filed 2026-07-21 | -$418.80M derived: sum of 4 quarters · filed 2026-07-21 | |
| 2026-03-31 | -$339.30M 10-Q · filed 2026-04-22 | -$299.80M derived: sum of 2 quarters · filed 2026-04-22 | -$387.80M derived: sum of 3 quarters · filed 2026-04-22 | -$358.30M derived: sum of 4 quarters · filed 2026-07-21 | |
| 2025-12-31 | $39.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | -$48.50M derived: sum of 2 quarters · filed 2026-02-03 | -$19.00M derived: sum of 3 quarters · filed 2026-07-21 | -$19.10M 10-K · filed 2026-02-03 | |
| 2025-09-30 | -$88.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-22 | -$58.50M derived: sum of 2 quarters · filed 2026-07-21 | -$58.60M 10-Q · filed 2025-10-22 | -$27.80M derived: sum of 4 quarters · filed 2026-07-21 | |
| 2025-06-30 | $29.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-21 | $29.40M 10-Q · filed 2026-07-21 | $60.20M derived: sum of 3 quarters · filed 2026-07-21 | $124.90M derived: sum of 4 quarters · filed 2026-07-21 | |
| 2025-03-31 | -$100.00K 10-Q · filed 2026-04-22 | $30.70M derived: sum of 2 quarters · filed 2026-04-22 | $95.40M derived: sum of 3 quarters · filed 2026-04-22 | $128.00M derived: sum of 4 quarters · filed 2026-04-22 | |
| 2024-12-31 | $30.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $95.50M derived: sum of 2 quarters · filed 2026-02-03 | $128.10M derived: sum of 3 quarters · filed 2026-02-03 | $135.30M 10-K · filed 2026-02-03 | |
| 2024-09-30 | $64.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-22 | $97.30M derived: sum of 2 quarters · filed 2025-10-22 | $104.50M 10-Q · filed 2025-10-22 | $324.30M derived: sum of 4 quarters · filed 2026-02-03 | |
| 2024-06-30 | $32.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-23 | $39.80M 10-Q · filed 2025-07-23 | $259.60M derived: sum of 3 quarters · filed 2026-02-03 | $302.90M derived: sum of 4 quarters · filed 2026-02-03 | |
| 2024-03-31 | $7.20M 10-Q · filed 2025-04-23 | $227.00M derived: sum of 2 quarters · filed 2026-02-03 | $270.30M derived: sum of 3 quarters · filed 2026-02-03 | $297.30M derived: sum of 4 quarters · filed 2026-02-03 | |
| 2023-12-31 | $219.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $263.10M derived: sum of 2 quarters · filed 2026-02-03 | $290.10M derived: sum of 3 quarters · filed 2026-02-03 | $280.80M 10-K · filed 2026-02-03 | |
| 2023-09-30 | $43.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-18 | $70.30M derived: sum of 2 quarters · filed 2024-10-18 | $61.00M 10-Q · filed 2024-10-18 | $144.30M derived: sum of 4 quarters · filed 2025-01-31 | |
| 2023-06-30 | $27.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-19 | $17.70M 10-Q · filed 2024-07-19 | $101.00M derived: sum of 3 quarters · filed 2025-01-31 | $162.90M derived: sum of 4 quarters · filed 2025-01-31 | |
| 2023-03-31 | -$9.30M 10-Q · filed 2024-04-19 | $74.00M derived: sum of 2 quarters · filed 2025-01-31 | $135.90M derived: sum of 3 quarters · filed 2025-01-31 | $161.60M derived: sum of 4 quarters · filed 2025-01-31 | |
| 2022-12-31 | $83.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-31 | $145.20M derived: sum of 2 quarters · filed 2025-01-31 | $170.90M derived: sum of 3 quarters · filed 2025-01-31 | $185.30M 10-K · filed 2025-01-31 | |
| 2022-09-30 | $61.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-20 | $87.60M derived: sum of 2 quarters · filed 2023-10-20 | $102.00M 10-Q · filed 2023-10-20 | $124.00M derived: sum of 4 quarters · filed 2024-01-31 | |
| 2022-06-30 | $25.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-24 | $40.10M 10-Q · filed 2023-07-24 | $62.10M derived: sum of 3 quarters · filed 2024-01-31 | $78.70M derived: sum of 4 quarters · filed 2024-01-31 | |
| 2022-03-31 | $14.40M 10-Q · filed 2023-04-20 | $36.40M derived: sum of 2 quarters · filed 2024-01-31 | $53.00M derived: sum of 3 quarters · filed 2024-01-31 | $121.70M derived: sum of 4 quarters · filed 2024-01-31 | |
| 2021-12-31 | $22.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-31 | $38.60M derived: sum of 2 quarters · filed 2024-01-31 | $107.30M derived: sum of 3 quarters · filed 2024-01-31 | $62.60M 10-K · filed 2024-01-31 | |
| 2021-09-30 | $16.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-21 | $85.30M derived: sum of 2 quarters · filed 2022-10-21 | $40.60M 10-Q · filed 2022-10-21 | ||
| 2021-06-30 | $68.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-22 | $24.00M 10-Q · filed 2022-07-22 | |||
| 2021-03-31 | -$44.70M 10-Q · filed 2022-04-22 | ||||
| 2020-12-31 | -$57.60M 10-K · filed 2023-02-10 | ||||
| 2019-12-31 | $8.00M 10-K · filed 2022-02-03 | ||||
| 2018-12-31 | -$31.90M 10-K · filed 2021-02-10 | ||||
| 2017-12-31 | -$60.20M 10-K · filed 2020-02-07 | -$62.90M 10-K · filed 2018-02-02 | |||
| 2016-12-31 | -$20.90M 10-K · filed 2019-02-04 | -$18.70M 10-K · filed 2017-02-06 | |||
| 2015-12-31 | -$4.60M 10-K · filed 2018-02-02 | ||||
| 2014-12-31 | $35.00M 10-K · filed 2017-02-06 | ||||
| 2013-12-31 | $38.50M 10-K · filed 2016-02-02 | ||||
| 2012-12-31 | $20.80M 10-K · filed 2015-02-06 | ||||
| 2011-12-31 | -$7.10M 10-K · filed 2014-02-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |